Identification of Endocrine Disruptors Via in vitro Diagnostic Tests: Current Methods and Future Aspects

biyomedikalozel5-1-24kapak

N. Nuray ULUSUa,b
aKoç University Faculty of Medicine, Department of Medical Biochemistry, İstanbul, Türkiye
bKoç University Research Center for Translational Medicine (KUTTAM), İstanbul, Türkiye

Ulusu NN. Identification of endocrine disruptors via in vitro diagnostic tests: Current methods and future aspects. In: Koçdor H, Pabuççuoğlu A, Zihnioğlu F, eds. Inflammation and in vitro Diagnostics. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.94-8.

Article Language: EN

ABSTRACT
Endocrine disruptor chemicals (EDCs) and their metabolites can interfere with the endocrine system of the organisms. EDCs can be classified as natural and synthetic chemicals. EDCs can enter the body’s airways, skin, placental, and breastfeeding according to their chemical properties. diverse cellular functions and alter the functions of the endocrine system, nervous system, reproduction system, and immune system and cause adverse health effects on the metabolism of the organism. Metabolic-disrupting chemicals, neurological disruptors, reproductive disruptors, vascular disruptors, and immune disruptors molecules can be classified under the subgroup of EDCs and cause various diseases and disorders. All these chemicals can mimic the body’s natural molecules can act as receptor antagonists or agonist molecules in many cellular major metabolic pathways, are involved in the energy production and utilization of the organisms, epigenetic alteration, signal transduction, receptor expression, hormone clearance, distribution, synthesis, transport and are involved in biochemical and physiological processes. Nowadays, EDCs can be detected by HPLC and gas chromatography methods. These exogenous compounds and their metabolites concentration must be determined via in vitro diagnostic assays. Determination of EDC via in vitro diagnostic testing, and detection in a normal routine biochemistry laboratory in the body fluids for instance blood, serum, plasma, urine, tear, spinal fluid, saliva, smear, amniotic fluid, cervical mucus, sperm, wound leakages, liquid biopsies, follicular fluid, pleural effusion, and sweat will be solve many health problems and opens the door of protect consumers from unhealthy cosmetic, and brings the discussions of water, food, air safety managements and standards.

Keywords: in vitro diagnostics; the imagination of future biochemistry; endocrine disruptor chemicals; metabolic-disrupting chemicals; metabolism

Referanslar

  1. Kokornaczyk MO, Bodrova NB, Baumgartner, S. Diagnostic tests based on pattern formation in drying body fluids - a mapping review. Colloids Surf B Biointerfaces. 2021;(208):112092. [Crossref]  [PubMed]
  2. Wang L, Xu W, Wang B, Si X, Li S. Methods and advances in the design, testing and development of ın vitro diagnostic ınstruments. Processes. 2023;(11):403. [Crossref]
  3. Reta DH, Tessema TS, Ashenef AS, Desta AF, Labisso WL, Gizaw ST, et al. Molecular and immunological diagnostic techniques of medical viruses. Int J Microbiol. 2020;(2020):1. [Crossref]  [PubMed]  [PMC]
  4. Nichols ZE, Geddes CD. Sample preparation and diagnostic methods for a variety of settings: a comprehensive review. Molecules. 2021;(26):5666. [Crossref]  [PubMed]  [PMC]
  5. Sunkara V, Kumar S, Sabaté del Río J, Kim I, Cho YK. Lab-on-a-disc for point-of-care infection diagnostics. Acc Chem Res. 2021;(54):3643. [Crossref]  [PubMed]
  6. Paul R, Ostermann E, Wei Q. Advances in point-of-care nucleic acid extraction technologies for rapid diagnosis of human and plant diseases. Biosens Bioelectron. 2020;(169):112592. [Crossref]  [PubMed]  [PMC]
  7. Yuan H, Chen P, Wan C, Li Y, Liu BF. Merging microfluidics with luminescence immunoassays for urgent point-of-care diagnostics of COVID-19. TrAC Trends in Analytical Chemistry. 2022;(157):116814. [Crossref]  [PubMed]  [PMC]
  8. Xu Z, Chen D, Li T, Yan J, Zhu J, He T, et al. Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification. Nat Commun. 2022;(13):6480. [Crossref]  [PubMed]  [PMC]
  9. Hauser J, Dale M, Beck O, Schwenk JM, Stemme G, Fredolini C, et al. Microfluidic device for patient-centric multiplexed assays with readout in centralized laboratories. Anal Chem. 2022;95(2):1350. [Crossref]  [PubMed]  [PMC]
  10. Porte J, Jenkins G, Tatler AL. Myofibroblast TGF-β activation measurement ın vitro. In; 2021;2299:99. [Crossref]  [PubMed]
  11. Judge A, Dodd MS. Metabolism. Essays Biochem. 2020;(64):607. [Crossref]  [PubMed]  [PMC]
  12. Ulusu NN. Evolution of enzyme kinetic mechanisms. J Mol Evol. 2015;(80):251. [Crossref]  [PubMed]  [PMC]
  13. Ulusu NN. Curious cases of the enzymes / neobiča istorija enzima. J Med Biochem. 2015;(34:)271. [Crossref]  [PubMed]  [PMC]
  14. Aydemir D, Ulusu NN. The Impact of the endocrine-disrupting chemicals on the glucose-6-phosphate dehydrogenase enzyme activity. Front Pharmacol. 2023;(14):1133741. [Crossref]  [PubMed]  [PMC]
  15. Aydemir D, Ulusu NN. The possible role of the endocrine disrupting chemicals on the premature and early menopause associated with the altered oxidative stress metabolism. Front Endocrinol (Lausanne). 2023;(14):1081704. [Crossref]  [PubMed]  [PMC]
  16. Lisco G, Giagulli VA, Iovino M, Guastamacchia E, Pergola G De, Triggiani V. Endocrine-disrupting chemicals: introduction to the theme. Endocr Metab Immune Disord Drug Targets. 2022;(22):677. [Crossref]  [PubMed]
  17. Ghosh A, Tripathy A, Ghosh D. Impact of endocrine disrupting chemicals (EDCs) on reproductive health of human. Proc Zool Soc. 2022;(75):16. [Crossref]
  18. Ahn C, Jeung EB. Endocrine-Disrupting Chemicals and Disease Endpoints. Int J Mol Sci. 2023;(6):5342. [Crossref]  [PubMed]  [PMC]
  19. Aydemir D, Karabulut G, Gok M, Barlas N, Ulusu NN. Data the DEHP ınduced changes on the trace element and mineral levels in the brain and testis tissues of rats. Data Brief. 2019;(26):104526. [Crossref]  [PubMed]  [PMC]
  20. Aydemir D, Oztasci B, Barlas N, Ulusu NN. Influence of the butylparaben administration on the oxidative stress metabolism of liver, kidney and spleen. Turkish Journal of Biochemistry. 2020;(45):689. [Crossref]
  21. Di Pietro G, Forcucci F, Chiarelli F. Endocrine disruptor chemicals and children's health. Int J Mol Sci. 2023;(24):2671. [Crossref]  [PubMed]  [PMC]
  22. Aydemir D, Karabulut G, Şimşek G, Gok, M, Barlas N, Ulusu NN. Impact of the di(2-ethylhexyl) phthalate administration on trace element and mineral levels in relation of kidney and liver damage in rats. Biol Trace Elem Res. 2018;(186):474. [Crossref]  [PubMed]  [PMC]
  23. Cocci P, Mosconi G, Arukwe A, Mozzicafreddo M, Angeletti M, Aretusi G, et al. Effects of diisodecyl phthalate on PPAR:RXR-dependent gene expression pathways in sea bream hepatocytes. Chem Res Toxicol. 2015;(28):935. [Crossref]
  24. Tang ZR, Xu XL, Deng SL, Lian ZX, Yu K. Oestrogenic endocrine disruptors in the placenta and the fetus. Int J Mol Sci. 2020;(21);1519. [Crossref]  [PubMed]  [PMC]
  25. Kim S, Thapar I, Brooks BW. Epigenetic changes by per- and polyfluoroalkyl substances (PFAS). Environmental Pollution. 2021;(279):116929. [Crossref]  [PubMed]
  26. Aydemir D, Öztaşcı B, Barlas N, Ulusu NN. Effects of butylparaben on antioxidant enzyme activities and histopathological changes in rat tissues. Archives of Industrial Hygiene and Toxicology. 2019;(70):315. [Crossref]  [PubMed]
  27. Papalou O, Kandaraki EA, Papadakis G, Diamanti-Kandarakis E. Endocrine disrupting chemicals: an occult mediator of metabolic disease. Front Endocrinol (Lausanne). 2019;(10):112. [Crossref]  [PubMed]  [PMC]
  28. Lin JY, Yin RX. Exposure to endocrine-disrupting chemicals and type 2 diabetes mellitus in later life. Expo Health. 2023;(15):199. [Crossref]
  29. Yan D, Jiao Y, Yan H, Liu T, Yan H, Yuan J. Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Environmental Health. 2022;(21):53. [Crossref]  [PubMed]  [PMC]
  30. Kahn LG, Trasande L. Environmental toxicant exposure and hypertensive disorders of pregnancy: recent findings. Curr Hypertens Rep. 2018;(20):87. [Crossref]  [PubMed]  [PMC]
  31. Fritsche K, Ziková-Kloas A, Marx-Stoelting P, Braeuning A. Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification. Int J Mol Sci. 2023;24(3):2686. [Crossref]  [PubMed]  [PMC]
  32. Aydemir D, Aydogan-Ahbab M, Barlas N, Ulusu NN. Effects of the in-utero dicyclohexyl phthalate and di-n-hexyl phthalate administration on the oxidative stress-induced histopathological changes in the rat liver tissue correlated with serum biochemistry and hematological parameters. Front Endocrinol (Lausanne). 2023;(14):1128202. [Crossref]  [PubMed]  [PMC]
  33. Marraudino M, Bonaldo B, Farinetti A, Panzica G, Ponti G, Gotti S. Metabolism disrupting chemicals and alteration of neuroendocrine circuits controlling food intake and energy metabolism. Front Endocrinol (Lausanne). 2019;(9):766. [Crossref]  [PubMed]  [PMC]
  34. Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism disrupting chemicals and metabolic disorders. Reproductive Toxicology. 2017;(68):3. [Crossref]  [PubMed]  [PMC]
  35. Sun J, Fang R, Wang H, Xu DX, Yang J, Huang X, et al. A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: Where exposomics meets metabolomics. Environ Int. 2022;(158):106941. [Crossref]  [PubMed]
  36. Akbay E, Ulusu NN, Töröner F, Ayvaz G, Taneri F, Aktürk M, et al. Effects of rosiglitazone treatment on the pentose phosphate pathway and glutathione-dependent enzymes in liver and kidney of rats fed a high-fat diet. Current Therapeutic Research. 2004;(65):79. [Crossref]  [PubMed]
  37. Gök M, Ulusu NN, Tarhan N, Tufan C, Ozansoy G, Arı N, et al. Flaxseed protects against diabetes-induced glucotoxicity by modulating pentose phosphate pathway and glutathione-dependent enzyme activities in rats. J Diet Suppl. 2016;(13):339. [Crossref]  [PubMed]
  38. Ulusu NN, Turan B. Beneficial Effects of selenium on some enzymes of diabetic rat heart. Biol Trace Elem Res. 2005;(103):207. [Crossref]  [PubMed]
  39. Ulusu NN, Acan NL, Turan B, Tezcan EF. Inhibition of glutathione reductase by cadmium ion in some rabbit tissues and the protective role of dietary selenium. Biol Trace Elem Res. 2003;(91):151. [Crossref]  [PubMed]
  40. Tuncay E, Seymen AA, Tanriverdi E, Yaras N, Tandogan B, Ulusu NN, et al. Gender related differential effects of omega-3e treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem. 2007;(304):255. [Crossref]  [PubMed]
  41. Turan B, Acan NL, Ulusu NN, Tezcan EF. A comparative study on effect of dietary selenium and vitamin E on some antioxidant enzyme activities of liver and brain tissues. Biol Trace Elem Res. 2001;(2):14. [Crossref]  [PubMed]
  42. Can B, Ulusu NN, Kilinç K, Leyla Acan N, Saran Y, Turan B. Selenium treatment protects diabetes-induced biochemical and ultrastructural alterations in liver tissue. Biol Trace Elem Res. 2005;(1-3):135-50. [Crossref]  [PubMed]
  43. Guz G, Oz E, Lortlar N, Ulusu NN, Nurlu N, Demirogullari B, et al. The effect of taurine on renal ischemia/reperfusion injury. Amino Acids. 2007;(3):411. [Crossref]  [PubMed]
  44. Pes GM, Dore MP. Acquired Glucose-6-Phosphate Dehydrogenase Deficiency. J Clin Med. 2022;(22):6689. [Crossref]  [PubMed]  [PMC]
  45. Fu X, He J, Zheng D, Yang X, Wang P, Tuo F, et al. Association of endocrine disrupting chemicals levels in serum, environmental risk factors, and hepatic function among 5- to 14-year-old children. Toxicology. 2022;(465):153011. [Crossref]  [PubMed]
  46. Wang Y, Li G, Zhu Q, Liao C. A multi-residue method for determination of 36 endocrine disrupting chemicals in human serum with a simple extraction procedure in combination of UPLC-MS/MS analysis. Talanta. 2019;(205):120144. [Crossref]  [PubMed]
  47. Vuong AM, Braun JM, Sjödin A, Calafat AM, Yolton K, Lanphear, B.P.; Chen, A. Exposure to endocrine disrupting chemicals (edcs) and cardiometabolic indices during pregnancy: The HOME study. Environ Int. 2021;(156):106747. [Crossref]  [PubMed]  [PMC]
  48. Li A, Wang F, Tao L, Ma C, Bi L, Song M, et al. Rapid and simultaneous determination of multiple endocrine-disrupting chemicals and their metabolites in human serum and urine samples. Talanta. 2022;(248):123639. [Crossref]  [PubMed]
  49. Ibor OR, Nnadozie P, Ogarekpe DM, Idogho O, Anyanti J, Aizobu D, et al. Public health implications of endocrine disrupting chemicals in drinking water and aquatic food resources in Nigeria: A state-of-the-science review. Sci Total Environ. 2023;858(Pt 2):159835. [Crossref]  [PubMed]